← Back to Search

Dietary Supplement

Clear Skin Formula for Acne

N/A
Recruiting
Research Sponsored by Ablon Skin Institute Research Center
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Subjects must have a facial non-cystic acne inflammatory lesion (papules and pustules) count with no less than 10 but no more than 50
Subjects must have a facial non-cystic acne non-inflammatory lesion (open and closed comedones) count with no less than 10 but no more than 100
Timeline
Screening 3 weeks
Treatment Varies
Follow Up baseline, day 14, day 28, day 56 and day 84 or end of study (up to 12 weeks)
Awards & highlights

Study Summary

This trial tests a supplement to reduce mild to moderate acne over 12 weeks in 18-40 yo men & women, with photos & questionnaires.

Who is the study for?
Healthy men and women aged 18-40 with mild to moderate non-cystic acne can join this study. They must have a certain number of facial acne lesions, agree to use specific skincare products provided by the sponsor, and for females, practice effective contraception. People using certain medications or treatments, those with other skin conditions or severe health issues, pregnant or nursing women, and individuals unable to follow the study protocol are excluded.Check my eligibility
What is being tested?
The trial is testing VitaMedica® Clear Skin Formula capsules against placebo capsules over 12 weeks in participants with non-cystic acne. It aims to see if the supplement helps reduce acne symptoms better than a placebo. Participants will take daily supplements, have their faces photographed regularly, and answer questionnaires about their skin condition.See study design
What are the potential side effects?
While not explicitly listed in the information provided, potential side effects may include digestive discomforts such as upset stomach or diarrhea since it's an oral supplement. Allergic reactions could occur but are likely rare given that it's designed for sensitive skin conditions like acne.

Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below
Select...
I have between 10 and 50 non-cystic pimples on my face.
Select...
I have between 10 and 100 non-inflammatory acne spots on my face.

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~baseline, day 14, day 28, day 56 and day 84 or end of study (up to 12 weeks)
This trial's timeline: 3 weeks for screening, Varies for treatment, and baseline, day 14, day 28, day 56 and day 84 or end of study (up to 12 weeks) for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Change in inflammatory lesion counts
Change in non-inflammatory lesion counts
Percentage/Proportion of subjects who achieve at least a one-grade reduction in the Modified IGA Score
Secondary outcome measures
Change in Analysis of the Clear Skin Formula Supplement Subject Satisfaction questionnaire
Change in Non-Cystic Acne Quality of Life questionnaire scores
Change in Non-Cystic Acne Self Assessment questionnaire scores
Other outcome measures
Change in the VISIA photography imaging of the left, right and front views of the face to include the (1) Percentile Rating, (2) Score Rating and (3) Feature Count Rating for Wrinkles, Texture, Pores, Red Areas and Porphyrins.
Changes in Clinical laboratory analyses of Complete Blood Count without Differential and with Platelets
Changes in Clinical laboratory analyses of Complete Metabolic Panel
+3 more

Trial Design

2Treatment groups
Active Control
Placebo Group
Group I: VitaMedica® Clear Skin Formula capsulesActive Control1 Intervention
Storage Instructions: Store in a cool, dry place. Contents: 60 Capsules Directions for Use: As a dietary supplement, take two capsules with food. Caution: Do not take if safety seal on bottle is broken. KEEP OUT OF REACH OF CHILDREN.
Group II: Placebo CapsulesPlacebo Group1 Intervention
Storage Instructions: Store in a cool, dry place. Contents: 60 Capsules Directions for Use: As a dietary supplement, take two capsules with food. Caution: Do not take if safety seal on bottle is broken. KEEP OUT OF REACH OF CHILDREN.

Find a Location

Who is running the clinical trial?

Grove Acquisition Subsidiary dba VitaMedicaUNKNOWN
Ablon Skin Institute Research CenterLead Sponsor
6 Previous Clinical Trials
296 Total Patients Enrolled

Media Library

VitaMedica® Clear Skin Formula capsules (Dietary Supplement) Clinical Trial Eligibility Overview. Trial Name: NCT05879406 — N/A
Non-Cystic Acne Research Study Groups: Placebo Capsules, VitaMedica® Clear Skin Formula capsules
Non-Cystic Acne Clinical Trial 2023: VitaMedica® Clear Skin Formula capsules Highlights & Side Effects. Trial Name: NCT05879406 — N/A
VitaMedica® Clear Skin Formula capsules (Dietary Supplement) 2023 Treatment Timeline for Medical Study. Trial Name: NCT05879406 — N/A

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

Is enrollment being offered to those of advanced age for this medical investigation?

"Per the study's eligibility requirements, only adults between 18 and 40 years old can take part in this research."

Answered by AI

Could I potentially join this research endeavor?

"Eligibility for this trial is limited to individuals between 18-40 years old that suffer from non-cystic acne. As of now, 40 patients are slated to be enrolled in the study."

Answered by AI

How many participants are engaging in this clinical research study?

"Affirmative. Information posted on clinicaltrials.gov demonstrates that this medical study is actively recruiting subjects, which began with the posting from May 22nd 2023 and was last updated 19th of May 2023. The research team requires 40 participants to be enrolled at 1 site."

Answered by AI

Is this experiment actively enrolling participants?

"Affirmative. According to clinicaltrials.gov, this current medical trial was first posted on May 22nd 2023 and has recently been updated as of May 19th 2023. The study is in search for 40 participants amongst a single location."

Answered by AI
~0 spots leftby May 2024